506 related articles for article (PubMed ID: 21490053)
21. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
[TBL] [Abstract][Full Text] [Related]
22. A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study.
Tetreault LA; Kopjar B; Vaccaro A; Yoon ST; Arnold PM; Massicotte EM; Fehlings MG
J Bone Joint Surg Am; 2013 Sep; 95(18):1659-66. PubMed ID: 24048553
[TBL] [Abstract][Full Text] [Related]
23. Cervical spondylotic myelopathy: 10 years of prospective outcome analysis of anterior decompression and fusion.
Chagas H; Domingues F; Aversa A; Vidal Fonseca AL; de Souza JM
Surg Neurol; 2005; 64 Suppl 1():S1:30-5; discussion S1:35-6. PubMed ID: 15967227
[TBL] [Abstract][Full Text] [Related]
24. Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice.
Genovese T; Menegazzi M; Mazzon E; Crisafulli C; Di Paola R; Dal Bosco M; Zou Z; Suzuki H; Cuzzocrea S
Shock; 2009 Apr; 31(4):367-75. PubMed ID: 18665052
[TBL] [Abstract][Full Text] [Related]
25. [The "pseudo-polyneuropathy" type sensory disturbances in cervical spondylotic myelopathy].
Yoshiyama Y; Tokumaru Y; Hattori T; Hirayama K
Rinsho Shinkeigaku; 1995 Feb; 35(2):141-6. PubMed ID: 7781229
[TBL] [Abstract][Full Text] [Related]
26. Approaches to spondylotic cervical myelopathy: conservative versus surgical results in a 3-year follow-up study.
Kadanka Z; Mares M; Bednaník J; Smrcka V; Krbec M; Stejskal L; Chaloupka R; Surelová D; Novotný O; Urbánek I; Dusek L
Spine (Phila Pa 1976); 2002 Oct; 27(20):2205-10; discussion 2210-1. PubMed ID: 12394893
[TBL] [Abstract][Full Text] [Related]
27. Anterior decompression and fusion for cervical spondylotic myelopathy.
Unnanuntana A
J Med Assoc Thai; 1998 Apr; 81(4):272-7. PubMed ID: 9623021
[TBL] [Abstract][Full Text] [Related]
28. Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application.
Yu WR; Fehlings MG
Acta Neuropathol; 2011 Dec; 122(6):747-61. PubMed ID: 22038545
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome.
Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Esposito E; Bramanti P; Cuzzocrea S
Shock; 2008 Jan; 29(1):32-41. PubMed ID: 17621255
[TBL] [Abstract][Full Text] [Related]
30. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
[TBL] [Abstract][Full Text] [Related]
31. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
32. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury.
Okada S; Nakamura M; Mikami Y; Shimazaki T; Mihara M; Ohsugi Y; Iwamoto Y; Yoshizaki K; Kishimoto T; Toyama Y; Okano H
J Neurosci Res; 2004 Apr; 76(2):265-76. PubMed ID: 15048924
[TBL] [Abstract][Full Text] [Related]
33. New experimental rabbit animal model for cervical spondylotic myelopathy.
Klironomos G; Karadimas S; Mavrakis A; Mirilas P; Savvas I; Papadaki E; Papachristou DJ; Gatzounis G
Spinal Cord; 2011 Nov; 49(11):1097-102. PubMed ID: 21788956
[TBL] [Abstract][Full Text] [Related]
34. A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury.
Fehlings MG; Skaf G
Spine (Phila Pa 1976); 1998 Dec; 23(24):2730-7. PubMed ID: 9879098
[TBL] [Abstract][Full Text] [Related]
35. Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy.
Moon ES; Karadimas SK; Yu WR; Austin JW; Fehlings MG
Neurobiol Dis; 2014 Feb; 62():394-406. PubMed ID: 24184328
[TBL] [Abstract][Full Text] [Related]
36. The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy.
Hirai T; Uchida K; Nakajima H; Guerrero AR; Takeura N; Watanabe S; Sugita D; Yoshida A; Johnson WE; Baba H
PLoS One; 2013; 8(5):e64528. PubMed ID: 23717624
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis in human compressive myelopathy due to metastatic neoplasia.
Newcombe RE; Finnie JW; Leonard AV; Manavis J; Reilly PL; Vink R; Blumbergs PC
Spine (Phila Pa 1976); 2015 Apr; 40(8):E450-7. PubMed ID: 25868101
[TBL] [Abstract][Full Text] [Related]
38. Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis.
van Landeghem FK; Felderhoff-Mueser U; Moysich A; Stadelmann C; Obladen M; Brück W; Bührer C
Pediatr Res; 2002 Feb; 51(2):129-35. PubMed ID: 11809905
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of cervical spondylotic myelopathy: Experimental and clinical studies.
Tominaga S
Nihon Geka Hokan; 1976 Mar; 45(2):51-68. PubMed ID: 988803
[No Abstract] [Full Text] [Related]
40. Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model.
Wang Z; Tan Y; Xu F
Tissue Cell; 2023 Apr; 81():102024. PubMed ID: 36669388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
